To include your compound in the COVID-19 Resource Center, submit it here.

Moderna advances pipeline with Phase II of AZD-8601

Moderna Therapeutics Inc. (Cambridge, Mass.) said AZD-8601 will be its first program to advance into Phase II testing. This quarter, the company plans to

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE